Factors associated with the acceptability of self-injection training by clients receiving DMPA-SC services from community pharmacies and patent and proprietary medicine vendors in Nigeria [PDF]
BMC Women's HealthBackground The self-administration of the subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has the potential to empower women and improve contraceptive use. Several studies have demonstrated the acceptability of the provider-administered DMPA-SC,
Toyin O. Akomolafe +7 more
doaj +4 more sources
Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda [PDF]
Contraception: X, 2019 Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is seen as a valuable innovation in family planning, but little is known about trends in DMPA-SC use or characteristics of users. Using data from Burkina Faso, the Democratic Republic of Congo (DRC) and Uganda, we measured trends in DMPA-SC and identified characteristics associated with DMPA-SC ...
Philip Anglewicz +2 more
exaly +5 more sources
How do pro-social tendencies and provider biases affect service delivery? Evidence from the rollout of self-injection of DMPA-SC in Nigeria [PDF]
BMC Women's HealthBackground Inconsistent provision of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) for self-injection (SI) undermines efforts to improve women’s reproductive health agency and access to self-care.
Calvin Chiu +8 more
doaj +3 more sources
Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers [PDF]
Contraception, 2018 To document the experience of three groups of Family Planning service providers participating in task-shifting for the provision of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) at the community level in the DRC.This article compares results from interviews with DMPA-SC providers in two separate pilot studies: 1) 53 medical and nursing ...
Julie H Hernández +2 more
exaly +5 more sources
Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC) [PDF]
Evaluation and Program Planning, 2018 In collaboration with ministries of health, PATH and key partners launched the first pilot introductions of subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda from July 2014 through June 2016.
Allen Namagembe
exaly +4 more sources
Understanding clients’ and providers’ perspectives on the implementation of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) for self-injection programming in Nigeria [PDF]
BMJ Global HealthSubcutaneous depot medroxyprogesterone acetate (DMPA-SC) is an injectable contraceptive method with a small needle and prefilled syringe system that has been approved for self-injection (SI) by clients. As DMPA-SC for SI programmes are being scaled, employing an implementation science lens is critical to understanding what works.
Elizabeth Omoluabi +9 more
doaj +4 more sources
Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States [PDF]
ContraceptionOBJECTIVES: Depot medroxyprogesterone acetate-subcutaneous (DMPA-SC) can be prescribed through telemedicine and self-administered, but data about availability, particularly during the COVID-19 pandemic, are limited.
Alison B Comfort +2 more
exaly +4 more sources
Determinants of DMPA-SC self-care/self-injectable contraceptive uptake among modern contraceptive users in Burkina Faso: findings from the 2021 demographic and health survey [PDF]
Frontiers in Global Women's HealthIntroductionThis study aimed to identify the determinants that influence the use of DMPA-SC/Sayana Press among women who use modern contraceptive methods in Burkina Faso.MethodsThis study used secondary data obtained from the 2021 Burkina Faso ...
Aristide Romaric Bado
doaj +2 more sources
Enhancing the Introduction and Scale Up of Self-Administered Injectable Contraception (DMPA-SC) in Health Systems (the EASIER Project): Protocol for Embedded Implementation Research [PDF]
JMIR Research Protocols, 2023 BackgroundThe introduction of self-administered injectable contraception presents an opportunity to address the unmet need for family planning.
Colin Baynes +3 more
doaj +2 more sources
Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda. [PDF]
Contracept X, 2021 To what extent is DMPA-SC reaching new users versus encouraging method switching among existing users? Though increasingly-popular, little is known about characteristics of women using DMPA-SC in SSA. We compared characteristics of women using DMPA-SC with those of other modern methods, and identified the extent to which women using DMPA-SC switched ...
Anglewicz P +7 more
europepmc +4 more sources